But a new study looking at the anti-amyloid drug gantenerumab could change all that. Published in the Lancet Neurology ...

But a new study looking at the anti-amyloid drug gantenerumab could change all that. Published in the Lancet Neurology ...

The FDA approval of Alnylam’s Amvuttra sets up a three-way race with Pfizer and BridgeBio, which both market transthyretin ...

A new study has found that an experimental drug appears to reduce the risk of Alzheimer' s-related dementia in people ...

The new findings center on a subset of 22 participants who received amyloid-removing drugs the longest, on average eight years. Long-term amyloid removal cut in half their risk of symptom onset, ...

Medically reviewed by Femi Aremu, PharmD Dementia is a loss of brain function that affects memory, thinking, judgment, ...

An experimental drug appears to reduce the risk of Alzheimer's-related dementia in people destined to develop the disease in ...

An experimental drug appears to reduce the risk of Alzheimer's-related dementia in people destined to develop the disease in ...

But the shingles studies published in 2024, along with a host of new papers, add weight to an alternative decades-old ...

Who's this for? If you have average credit and are looking to build up to a good or excellent credit score, it's a good idea to consider a credit card designed for average credit applicants ...

You’re doing the work, you’re feeling the burn, but how long does it actually take to build muscle? Building muscle isn’t just a matter of showing up and working out however and whenever you ...